TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9513097

Group type: EXPERIMENTAL
Intervention: Panavia EX adhesive
Number of subjects: 3

Group type: COMPARATOR
Intervention: Copalite varnish
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High copper amalgam
Number of subjects: 3
Study: 7740378

Group type: EXPERIMENTAL
Intervention: Osteoporosis (OP) group
Number of subjects: 181

Group type: COMPARATOR
Intervention: Non-OP control group
Number of subjects: 181
Study: 3168567

Group type: COMPARATOR
Intervention: Methylprednisolone 80 mg/24 h and aminophylline by continuous infusion (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release theophylline and methylprednisolone 80 mg in two equally divided doses by mouth (Group B)
Number of subjects: 0
Study: 31515719

Group type: EXPERIMENTAL
Intervention: Inguinal lymphadenectomy
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ilio-inguinal lymphadenectomy
Number of subjects: 69
Study: 28592282

Group type: EXPERIMENTAL
Intervention: RAGT + VR (40 sessions of Lokomat with VR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: RAGT - VR (Lokomat without VR)
Number of subjects: 24
Study: 25100217

Group type: EXPERIMENTAL
Intervention: Driving with a cautious peer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Driving with a risky peer
Number of subjects: 0
Study: 24332472

Group type: EXPERIMENTAL
Intervention: Haptic stimulus (touching a pad with index finger)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Haptic stimulus (withdrawal of contact with pad)
Number of subjects: 22
Study: 23306563

Group type: EXPERIMENTAL
Intervention: Myofascial trigger point deactivation (10 sessions)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham deactivation (10 sessions)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Myofascial trigger point deactivation
Number of subjects: 71
Study: 20560622

Group type: EXPERIMENTAL
Intervention: Brown diet (BD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: White diet (WD)
Number of subjects: 18
Study: 17564002

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 4 mg i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ondansetron, 4 mg i.v.
Number of subjects: 60
Study: 15606417

Group type: EXPERIMENTAL
Intervention: Randomization-based methods for times to repeated events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structural accelerated failure time models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artificial censoring techniques
Number of subjects: 0
Study: 11522614

Group type: EXPERIMENTAL
Intervention: MEN 11420 (8 mg intravenously)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 9632121

Group type: EXPERIMENTAL
Intervention: Serum sex hormone-binding globulin (SHBG)
Number of subjects: 58
Study: 7829401

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide plus dexamethasone (HDMP+Dx)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Granisetron plus dexamethasone (GRN+Dx)
Number of subjects: 54
Study: 2826952

Group type: EXPERIMENTAL
Intervention: 20 micrograms recombinant gamma‐interferon (rec‐gamma‐IFN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1.5 mg dexamethasone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: rec‐gamma‐IFN
Number of subjects: 10

Group type: COMPARATOR
Intervention: pituitary cell culture
Number of subjects: 10
Study: 30535174

Group type: EXPERIMENTAL
Intervention: Parent-implemented communication treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 19
Study: 27501654

Group type: EXPERIMENTAL
Intervention: Dorzolamide-timolol treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Balanced salt solution (Control)
Number of subjects: 90
Study: 24712047

Group type: EXPERIMENTAL
Intervention: 600 mL liquid test meal consumed three times (breakfast, lunch, dinner)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 300 mL liquid test meal consumed six times (breakfast, snack, lunch, snack, dinner, snack)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 600 mL regimen
Number of subjects: 15
Study: 22159169

Group type: EXPERIMENTAL
Intervention: Oral azithromycin (1 g)
Number of subjects: 1452

Group type: COMPARATOR
Intervention: Topical tetracycline (twice per day for 6 weeks)
Number of subjects: 1452
Study: 20864405

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 833

Group type: COMPARATOR
Intervention: Vincristine
Number of subjects: 833
Study: 19009864

Group type: EXPERIMENTAL
Intervention: Bladeless trocar (Optiview system)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hasson open trocar
Number of subjects: 60
Study: 15997934

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Glass ionomer
Number of subjects: 70

Group type: COMPARATOR
Intervention: No barrier (positive control)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sticky wax (negative control)
Number of subjects: 70
Study: 12760313

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg/day
Number of subjects: 202

Group type: COMPARATOR
Intervention: Naproxen 1 g/day
Number of subjects: 202
Study: 10362745

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 12

Group type: COMPARATOR
Intervention: L-NMMA
Number of subjects: 12

Group type: COMPARATOR
Intervention: L-arginine
Number of subjects: 12
Study: 8684755

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound and graded outpatient tocolysis
Number of subjects: 1765

Group type: COMPARATOR
Intervention: Conventional methods without transvaginal ultrasound
Number of subjects: 1765
Study: 8477316

Group type: EXPERIMENTAL
Intervention: Midnight removal of urinary catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0600 removal of urinary catheters
Number of subjects: 0
Study: 3698608

Group type: EXPERIMENTAL
Intervention: Cefamandole nafate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cephalothin sodium
Number of subjects: 80
Study: 30187872

Group type: EXPERIMENTAL
Intervention: ethinyl oestradiol/cyproterone tablets (Group A)
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: desogestrel/ethinyl oestradiol tablets (Group B)
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: metformin (for women with insulin resistance)
Number of subjects: 712
Study: 24567309

Group type: EXPERIMENTAL
Intervention: Daily oral supplementation of multivitamins (B-complex, C and E)
Number of subjects: 2387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2387
Study: 22864036

Group type: EXPERIMENTAL
Intervention: Intraocular irrigation fluid with epinephrine 1:1,000,000
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intraocular irrigation fluid without epinephrine (Control)
Number of subjects: 88
Study: 20141304

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 17118949

Group type: EXPERIMENTAL
Intervention: Self management (n=73)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care (n=67)
Number of subjects: 140
Study: 15842871

Group type: EXPERIMENTAL
Intervention: Adjustable appliance
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ordinary mandibular advancing appliance (Control)
Number of subjects: 30
Study: 14606378

Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil with 50 mg/h of lidocaine (group T-AL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil (group T-A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil (group L-A)
Number of subjects: 45
Study: 10065387

Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Hospital care
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Job rehabilitation
Number of subjects: 180
Study: 7711452

Group type: EXPERIMENTAL
Intervention: Propofol and midazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol and fentanyl
Number of subjects: 60
Study: 2675854

Group type: EXPERIMENTAL
Intervention: Sustained release oral salbutamol (8 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Salbutamol (8 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1171083

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 143

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 143

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 143

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 31609772

Group type: EXPERIMENTAL
Intervention: Early triggered palliative care consultation
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study: 28017964

Group type: EXPERIMENTAL
Intervention: Intragastric balloon plus lifestyle intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Lifestyle intervention alone
Number of subjects: 255
Study: 26253869

Group type: EXPERIMENTAL
Intervention: S‐1 (40 mg/m² twice per day) for 2 consecutive weeks repeated every 3 weeks for 1 year
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cisplatin (CDDP) (60 mg/m²) on day 1 plus oral S‐1 (40 mg/m² twice per day) for 2 consecutive weeks repeated every 3 weeks for four cycles
Number of subjects: 200
Study: 22173149

Group type: EXPERIMENTAL
Intervention: Morning administration (8:00 to 10:00 a.m.)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Afternoon administration (1:00 to 3:00 p.m.)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: ADHD classification using TOVA
Number of subjects: 122
Study: 21381157

Group type: EXPERIMENTAL
Intervention: Stepped care ERP (3 sessions over 6 weeks of low-intensity counseling with ERP bibliotherapy, followed by therapist-administered ERP if needed)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ERP (therapist-administered ERP with no lower-intensity lead-in)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Stepped care ERP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ERP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stepped care ERP and Standard ERP
Number of subjects: 30
Study: 18022318

Group type: EXPERIMENTAL
Intervention: Active laser treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 43
Study: 16546864

Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg)
Number of subjects: 15
Study: 12570118

Group type: EXPERIMENTAL
Intervention: Individualised asthma programme directed at behavioural change
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 23
Study: 10838018

Group type: EXPERIMENTAL
Intervention: Single dose intravenous administration of ivabradine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Multiple dose oral administration of ivabradine every 12 hours
Number of subjects: 66
Study: 9178278

Group type: EXPERIMENTAL
Intervention: Glutamine-containing parenteral nutrition (PN)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control parenteral nutrition (isonitrogenous, isoenergetic)
Number of subjects: 84
Study: 8398222

Group type: EXPERIMENTAL
Intervention: Behavioral risk factor surveys (BRFSs) for women binge drinkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral risk factor surveys (BRFSs) for older drivers reporting drinking and driving or multiple drinking problems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CAGE score of 2 or more for older drivers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Problem drinking behaviors in male drivers under 65 years of age
Number of subjects: 0
Study: 3773498

Group type: EXPERIMENTAL
Intervention: Group 2 (caval atrial cannula)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group 1 (single-port drainage cannulae)
Number of subjects: 20
Study: 31567674

Group type: EXPERIMENTAL
Intervention: Cognitive Training Tool (CTT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard operation manual with surgical videos
Number of subjects: 36
Study: 29617350

Group type: EXPERIMENTAL
Intervention: Rice Bran Soymilk (RBS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sugar-Free Soymilk (SFS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: White Bread (Control)
Number of subjects: 17
Study: 27680405

Group type: EXPERIMENTAL
Intervention: New chimney-equipped stoves (n=155)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Open-fire stoves (n=179)
Number of subjects: 334
Study: 22493975

Group type: EXPERIMENTAL
Intervention: BML training (30% of 1-RM load, 5-7 sets of 15 repetitions, 3 times per week for 8 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BML training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 24
Study: 22386043

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) 5 ppm for up to 28 days
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 20436058

Group type: EXPERIMENTAL
Intervention: VSL#3
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 18676075

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg/d
Number of subjects: 10060

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10060

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 10060
Study: 15807716

Group type: EXPERIMENTAL
Intervention: NFV 625 mg (1250 mg bid)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: NFV 625 mg
Number of subjects: 126

Group type: COMPARATOR
Intervention: NFV 250 mg
Number of subjects: 126
Study: 12364482

Group type: EXPERIMENTAL
Intervention: Somatostatin (SRIF-14) 2.0 micro g/kg/h i.v. over 120 min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cortistatin (CST-14) 2.0 micro g/kg/h i.v. over 120 min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 10591454

Group type: EXPERIMENTAL
Intervention: Nocturnal dental appliance for mandibular advancement
Number of subjects: 95

Group type: COMPARATOR
Intervention: Surgical treatment, uvulopalatopharyngoplasty
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Somnography with dental appliance
Number of subjects: 95

Group type: COMPARATOR
Intervention: Somnography without dental appliance
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Adverse events from dental appliance
Number of subjects: 95
Study: 9156924

Group type: EXPERIMENTAL
Intervention: Paroxysmal atrial fibrillation (PAF) during ischemic heart disease (IHD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy control group (group IV)
Number of subjects: 75
Study: 1931746

Group type: EXPERIMENTAL
Intervention: 2% Remodent and 0.2% NaF solutions
Number of subjects: 123

Group type: COMPARATOR
Intervention: 0.2% NaF solutions (Control group)
Number of subjects: 123
Study: 7010881

Group type: EXPERIMENTAL
Intervention: Transcutaneous nerve stimulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mock stimulation
Number of subjects: 70
Study: 31565869

Group type: EXPERIMENTAL
Intervention: Standard group (STD) - supervised exercise program (300 min/wk of moderate-intensity aerobic exercise) during months 0 to 6
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sequential group (SEQ) - refrained from exercise during months 0 to 6, then supervised exercise program during months 7 to 12
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Standard group (STD) - weight regain between 6 and 18 months
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sequential group (SEQ) - weight change between 6 and 18 months
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups at 18 months
Number of subjects: 170
Study: 30160222

Group type: EXPERIMENTAL
Intervention: Whole eggs (EGG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Egg whites (WHITE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egg yolks (YOLK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 0
Study: 26447687

Group type: EXPERIMENTAL
Intervention: Combined SPT and pregabalin 300 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: SPT alone
Number of subjects: 40
Study: 24372921

Group type: EXPERIMENTAL
Intervention: Toothbrushing with fluoride-containing dentifrice (1,100 ppm fluoride as sodium fluoride)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Toothbrushing with placebo dentifrice (0 ppm fluoride)
Number of subjects: 16
Study: 22309472

Group type: EXPERIMENTAL
Intervention: Exposure‐only therapy (Ex)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Exposure‐based treatment combined with cognitive restructuring (ExCR)
Number of subjects: 108
Study: 19772765

Group type: EXPERIMENTAL
Intervention: Mold-sensitive subjects (based on skin test reactivity)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Mold-sensitive subjects (SPT reactive subgroup)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nonmold-sensitive subjects
Number of subjects: 34
Study: 17705570

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg/day for 6 weeks
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg/day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Quinapril 40 mg/day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Quinapril 20 mg/day + HCTZ 12.5 mg/day
Number of subjects: 200
Study: 15479540

Group type: EXPERIMENTAL
Intervention: Respondents who selected more attributes as important to their attitude
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambivalent attitudes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-ambivalent attitudes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambivalent attitude-holders
Number of subjects: 0
Study: 11552924

Group type: EXPERIMENTAL
Intervention: 1-week regimen with ranitidine bismuth citrate 400 mg b.d. for 7 days
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 2-week regimen with ranitidine bismuth citrate 400 mg b.d. for 14 days
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 4-week regimen with ranitidine bismuth citrate 400 mg b.d. for 28 days
Number of subjects: 86
Study: 9636857

Group type: EXPERIMENTAL
Intervention: BACI prior to C. parvum challenge (BACI group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BACI prior to and 30 minutes after challenge (reinforced BACI group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonfat milk placebo prior to and 30 minutes after challenge
Number of subjects: 20
Study: 7931747

Group type: EXPERIMENTAL
Intervention: Algorithm condition (provision of intervention algorithm at each patient visit)
Number of subjects: 527

Group type: COMPARATOR
Intervention: No-algorithm condition
Number of subjects: 527
Study: 3144443

Group type: EXPERIMENTAL
Intervention: 0.3 mg.kg‐1 nalbuphine intravenously
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.1 mg.kg‐1 nalbuphine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.3 mg.kg‐1 nalbuphine
Number of subjects: 20
Study: 29256032

Group type: EXPERIMENTAL
Intervention: Simulation training (SIM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Didactic ECT curriculum (non‐SIM)
Number of subjects: 35
Study: 27412799

Group type: EXPERIMENTAL
Intervention: Taurine (3 g per day)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Magnesium (340 mg per day)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Taurine (3% solution) and/or high-Mg diet (600 mg per 100 g)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (WKY rats)
Number of subjects: 2
Study: 24105406

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion with Roux-en-Y gastric bypass (BPD-RYGBP)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGBP)
Number of subjects: 130
Study: 22615543

Group type: EXPERIMENTAL
Intervention: In utero tenofovir exposure
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Combination ART in pregnancy
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Maternal ART regimens
Number of subjects: 302
Study: 20691300

Group type: EXPERIMENTAL
Intervention: On-statin CETP mass
Number of subjects: 3218

Group type: EXPERIMENTAL
Intervention: CETP mass greater than the median
Number of subjects: 3218

Group type: EXPERIMENTAL
Intervention: CETP mass quartiles
Number of subjects: 3218
Study: 18726564

Group type: EXPERIMENTAL
Intervention: Egg-fed group (2 eggs a day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non-egg-fed group
Number of subjects: 45
Study: 16911650

Group type: EXPERIMENTAL
Intervention: FACT questionnaire
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All questionnaires
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Quality of life questionnaires
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Length of questionnaire
Number of subjects: 80
Study: 14505263

Group type: EXPERIMENTAL
Intervention: GnRH-Agonist induced reversible ovarian suppression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Progestins
Number of subjects: 0
Study: 10539122

Group type: EXPERIMENTAL
Intervention: Patients followed by a general practitioner
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Patients followed by a neurologist
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Overall costs
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Clinical indicators
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Ancillary care costs
Number of subjects: 294
Study: 8834342

Group type: EXPERIMENTAL
Intervention: Rehabilitation at home for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 43
Study: 1677266

Group type: EXPERIMENTAL
Intervention: 3 mg of alprazolam
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6362765

Group type: EXPERIMENTAL
Intervention: Benztropine mesylate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 29904047

Group type: EXPERIMENTAL
Intervention: Integrated RES and BoNT
Number of subjects: 60

Group type: COMPARATOR
Intervention: BoNT
Number of subjects: 60

Group type: COMPARATOR
Intervention: RES
Number of subjects: 60